Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
Returns Beta
Beta has not been calculated since enough price history is not available
News
No Recent News for the Company
Announcements 
Regulation 30 Disclosure - Entry Into The Urology Therapy Segment
21-Nov-2025 | Source : BSERegulation 30 Disclosure - Entry into the Urology Therapy Segment
Intimation Of New Product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL)
12-Nov-2025 | Source : BSEIntimation of new product- SHIROVITA HAIR OIL (AYURVEDIC HAIR OIL)
Intimation Of New Product- ENZYKING SYRUP
12-Nov-2025 | Source : BSEIntimation of new product- ENZYKING SYRUP
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
2.91
Debt to EBITDA (avg)
1.71
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.82
Tax Ratio
27.80%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
12.83%
ROCE (avg)
28.87%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
36
Industry P/E
34
Price to Book Value
4.93
EV to EBIT
22.46
EV to EBITDA
21.23
EV to Capital Employed
6.49
EV to Sales
4.11
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
28.87%
ROE (Latest)
13.64%
Technicals key factors
Indicator
Weekly
Monthly
No records
Shareholding Snapshot : Jun 2025
Shareholding Compare (%holding) 
Majority shareholders
Promoters
Pledged Promoter Holdings
None
Mutual Funds
Held by 0 Schemes
FIIs
Held by 4 FIIs (10.03%)
Promoter with highest holding
Kapilbhai Hasmukhbhai Chandarana (11.3%)
Highest Public shareholder
Saint Capital Fund (4.29%)
Individual Investors Holdings
11.55%
Half Yearly Results Snapshot (Standalone) - Sep'25
Sep'25
Sep'24
Change(%)
Net Sales
14.38
9.76
47.34%
Operating Profit (PBDIT) excl Other Income
2.93
1.98
47.98%
Interest
0.43
0.11
290.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.75
1.31
33.59%
Operating Profit Margin (Excl OI)
20.38%
20.29%
0.09%
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
Annual Results Snapshot (Standalone) - Mar'25
Mar'25
Mar'24
Change(%)
Net Sales
24.56
17.86
37.51%
Operating Profit (PBDIT) excl Other Income
4.75
1.54
208.44%
Interest
0.47
0.24
95.83%
Exceptional Items
0.00
0.00
Standalone Net Profit
2.96
0.80
270.00%
Operating Profit Margin (Excl OI)
19.34%
8.62%
10.72%
Values in Rs Cr.
Net Sales
Not Applicable: The company has declared_date for only one period
Standalone Net Profit
Not Applicable: The company has declared_date for only one period
About Aptus Pharma Ltd 
Aptus Pharma Ltd
Micro Cap
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






